Abramson Cancer Center — Philadelphia, Pennsylvania

Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Abramson Cancer Center has participated in 30 clinical trials with 14 currently active.

Therapeutic areas: Colorectal Neoplasms Malignant, Metastatic Melanoma, GBM.

Sponsors: Abramson Cancer Center at Penn Medicine, Center for International Blood and Marrow Transplant Research, University of Pennsylvania.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center?

Abramson Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center conducted?

Abramson Cancer Center has 30 clinical trials on record, with 14 currently active. Their work covers Colorectal Neoplasms Malignant, Metastatic Melanoma, GBM.

Is Abramson Cancer Center accredited by Crixeo Health?

Abramson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.